Sarepta Therapeutics | SRPT - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amgen USD 5.87B 1.02B 2026-03
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Capricor Therapeutics 11.13M 8.87M 2024-12
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Eli Lilly USD 16.22B 301.7M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
Incyte USD 1.57B 400.89M 2026-06
Insmed USD 356.19M 99.73M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD -248M 11.29B 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.71B 602M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Tectonic Therapeutic USD 0 0 2025-03
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06